O
OrbiMed’s Dyne Therapeutics DYN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.82M | Buy |
1,031,400
+16,789
| +2% | +$160K | 0.25% | 58 |
|
|
2025
Q1 | $10.6M | Sell |
1,014,611
-212,469
| -17% | -$2.22M | 0.25% | 59 |
|
|
2024
Q4 | $28.9M | Buy |
1,227,080
+518,680
| +73% | +$12.2M | 0.59% | 45 |
|
|
2024
Q3 | $25.4M | Hold |
708,400
| – | – | 0.46% | 55 |
|
|
2024
Q2 | $25M | Hold |
708,400
| – | – | 0.49% | 51 |
|
|
2024
Q1 | $20.1M | Buy |
+708,400
| New | +$20.1M | 0.37% | 64 |
|
|
2022
Q4 | – | Sell |
-220,400
| Closed | -$2.8K | – | 119 |
|
|
2022
Q3 | $2.8K | Buy |
+220,400
| New | +$2.8K | 0.05% | 114 |
|
|
2021
Q3 | – | Sell |
-350,000
| Closed | -$7.36M | – | 174 |
|
|
2021
Q2 | $7.36M | Hold |
350,000
| – | – | 0.07% | 137 |
|
|
2021
Q1 | $5.44M | Hold |
350,000
| – | – | 0.05% | 140 |
|
|
2020
Q4 | $7.35M | Hold |
350,000
| – | – | 0.06% | 132 |
|
|
2020
Q3 | $7.07M | Buy |
+350,000
| New | +$7.07M | 0.09% | 118 |
|